Literature DB >> 34145318

Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides.

Leidy Pedraza1,2, Milena Camargo1,3, Darwin A Moreno-Pérez1,3, Ricardo Sánchez1,4, Luisa Del Río-Ospina1, Indira M Báez-Murcia1, Manuel E Patarroyo1,4,5, Manuel A Patarroyo6,7,8.   

Abstract

HLA class II (HLA-II) genes' polymorphism influences the immune response to Chlamydia trachomatis (Ct), it is considered a sexually transmitted infection. However, associations between HLA-II alleles and Ct-infection have been little explored in humans; this study was thus aimed at determining HLA-DRB1-DQB1 alleles/haplotypes' effect on Ct-infection outcome in a cohort of Colombian women. Cervical sample DNA was used as template for detecting Ct by PCR and typing HLA-DRB1-DQB1 alleles/haplotypes by Illumina MiSeq sequencing. Survival models were adjusted for identifying the alleles/haplotypes' effect on Ct-outcome; bioinformatics tools were used for predicting secreted bacterial protein T- and B-cell epitopes. Sixteen HLA-DRB1 alleles having a significant effect on Ct-outcome were identified in the 262 women analysed. DRB1*08:02:01G and DRB1*12:01:01G were related to infection-promoting events. Only the DQB1*05:03:01G allele related to clearance/persistence events was found for HLA-DQB1. HLA-DRB1 allele homozygous women were associated with events having a lower probability of clearance and/or early occurrence of persistence. Twenty-seven peptides predicted in silico were associated with protective immunity against Ct; outer membrane and polymorphic membrane protein-derived peptides had regions having dual potential for being T- or B-cell epitopes. This article describes HLA-DRB1-DQB1 alleles/haplotypes related to Ct-infection resolution and the peptides predicted in silico which might probably be involved in host immune response. The data provides base information for developing future studies leading to the development of effective prevention measures against Ct-infection.

Entities:  

Year:  2021        PMID: 34145318     DOI: 10.1038/s41598-021-92294-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents.

Authors:  William M Geisler; Jianming Tang; Chengbin Wang; Craig M Wilson; Richard A Kaslow
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

2.  Molecular characterization of lower vaginal swabs for Human papilloma virus in association with Chlamydia trachomatis infection in Cameroonian Women.

Authors:  Pythagore Fogue; Geraldo Djeudong; George Bouting; Elom Aglago; Gustave Simo; Smiths Lueong
Journal:  J Infect Public Health       Date:  2017-09-14       Impact factor: 3.718

3.  Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Caixia Shen; Peter Andersen; Robert C Brunham
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

Review 4.  Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.

Authors:  Louise M Hafner; Peter Timms
Journal:  Expert Rev Vaccines       Date:  2017-12-21       Impact factor: 5.217

Review 5.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

Review 6.  Sexually transmitted infections: challenges ahead.

Authors:  Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley
Journal:  Lancet Infect Dis       Date:  2017-07-09       Impact factor: 25.071

7.  Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial sexually transmitted diseases, endometritis, and fertility among women with clinical pelvic inflammatory disease.

Authors:  Roberta B Ness; Robert C Brunham; Caixia Shen; Debra C Bass
Journal:  Sex Transm Dis       Date:  2004-05       Impact factor: 2.830

8.  Identifying the HLA DRB1-DQB1 molecules and predicting epitopes associated with high-risk HPV infection clearance and redetection.

Authors:  Luisa Del Río-Ospina; Milena Camargo; Sara C Soto-De León; Ricardo Sánchez; Darwin A Moreno-Pérez; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

9.  Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0.

Authors:  Carolyn K Hurley; Jane Kempenich; Kim Wadsworth; Jürgen Sauter; Jan A Hofmann; Daniel Schefzyk; Alexander H Schmidt; Pablo Galarza; Maria B R Cardozo; Malgorzata Dudkiewicz; Lucie Houdova; Pavel Jindra; Betina S Sorensen; Latha Jagannathan; Ankit Mathur; Tiina Linjama; Tigran Torosian; Rafi Freudenberger; Anastasios Manolis; John Mavrommatis; Nezih Cereb; Sigal Manor; Nira Shriki; Nicoletta Sacchi; Reem Ameen; Raewyn Fisher; Heather Dunckley; Irene Andersen; Ahmed Alaskar; Mohsen Alzahrani; Ali Hajeer; Dunia Jawdat; Grazia Nicoloso; Pawinee Kupatawintu; Louise Cho; Ashminder Kaur; Mats Bengtsson; Jason Dehn
Journal:  HLA       Date:  2020-01-31       Impact factor: 4.513

View more
  1 in total

1.  Genetic susceptibility loci for Chlamydia trachomatis endometrial infection influence expression of genes involved in T cell function, tryptophan metabolism and epithelial integrity.

Authors:  Wujuan Zhong; Avinash Kollipara; Yutong Liu; Yuhan Wang; Catherine M O'Connell; Taylor B Poston; Kacy Yount; Harold C Wiesenfeld; Sharon L Hillier; Yun Li; Toni Darville; Xiaojing Zheng
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.